JKS [JinkoSolar] 6-K: (Original Filing)
[JinkoSolar Holding Co., Ltd. S ONGGEN HANG / Longgen Zhang]
JKS [JinkoSolar] 6-K: JinkoSolar Holding Co., Ltd. S ONGGEN HANG /
[JinkoSolar Holding Co., Ltd. S ONGGEN HANG / Longgen Zhang]
CO [China Cord Blood] 6-K: (Original Filing)
[China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 31.3% Increase in 3Q11 Revenue 29.4% Increase in 3Q11 Net Income Attributable to Shareholders Conference Call to be Held at 8 pm ET February 28, 2010 HONG KONG, China, February 28, 2011 -- China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), China’s]
MR [Mindray Medical International] 6-K: Mindray Announces 2010 Fourth Quarter and Full Year
[Mindray Announces 2010 Fourth Quarter and Full Year Results SHENZHEN, China, Feb. 28, 2011 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2010.]
JOBS [51JOB] 6-K: (Original Filing)
[Contact: Rebecca Liu 51job, Inc. Reports Fourth Quarter and Fiscal Year 2010 Financial Results SHANGHAI, China, February 28, 2011 51job, Inc. (Nasdaq: JOBS) Fourth Quarter 2010 Financial Highlights: Fiscal Year 2010 Financial Highlights: Commenting on the results, Rick Yan, President and Chief Executive Officer of 51job, Inc., said, Our solid performance in the fourth quarter of 2010 concluded a successful] [FORM 6-K 51job, Inc. Cayman Islands (Jurisdiction of incorporation or organization) Building 3 x x n/a 51job, Inc. is furnishing under the cover of Form 6-K: 99.1 Press release regarding fourth quarter and fiscal year 2010 unaudited financial results dated February 28, 2011 51job, Inc. Rick Yan President and Chief Executive Officer Description 99.1 Press release regarding]
JKS [JinkoSolar] 6-K: (Original Filing)
[JinkoSolar S ONGGEN HANG / Longgen Zhang Chief Financial Officer 2 3 JinkoSolar Announces Fourth Quarter and Full Year 2010 Results STYLE="font-family:Times New Roman" SIZE="2"> Fourth Quarter Shipments and Total Revenues Exceeded High-end Guidance by 16.1% and 21.7%, respectively; Full Year 2010 Netomereased over 900% with Diluted Earnings perS of US$6.62;]
TPI [TIANYIN PHARMACEUTICAL] DEF 14A: (Original Filing)
[SCHEDULE 14A INFORMATION INFORMATION REQUIRED IN PROXY STATEMENT Check the appropriate box: [_] Preliminary Proxy Statement [_] Confidential, for Use of the [X] Definitive Proxy Statement [_] Definitive Additional Materials [_] Soliciting Material under Rule 14a-12 Tianyin Pharmaceutical Co., Inc. Payment of Filing Fee (Check the appropriate box): [X] No fee required [_] Fee computed on table below per Exchange]
JKS [JinkoSolar] 6-K: JinkoSolar S ONGGEN HANG / Longgen Zhang Chief
[JinkoSolar S ONGGEN HANG / Longgen Zhang Chief Financial Officer 2 3 JinkoSolar Announces Fourth Quarter and Full Year 2010 Results STYLE="font-family:Times New Roman" SIZE="2"> Fourth Quarter Shipments and Total Revenues Exceeded High-end Guidance by 16.1% and 21.7%, respectively; Full Year 2010 Netomereased over 900% with Diluted Earnings perS of US$6.62;]
TPI [TIANYIN PHARMACEUTICAL] DEF 14A: SCHEDULE 14A INFORMATION INFORMATION REQUIRED IN PROXY STATEMENT
[SCHEDULE 14A INFORMATION INFORMATION REQUIRED IN PROXY STATEMENT Check the appropriate box: [_] Preliminary Proxy Statement [_] Confidential, for Use of the [X] Definitive Proxy Statement [_] Definitive Additional Materials [_] Soliciting Material under Rule 14a-12 Tianyin Pharmaceutical Co., Inc. Payment of Filing Fee (Check the appropriate box): [X] No fee required [_] Fee computed on table below per Exchange]
